SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DEGLI UBERTI, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.610
AS - Asia 18.545
EU - Europa 16.693
SA - Sud America 2.906
AF - Africa 398
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 20
Totale 72.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.906
SG - Singapore 6.926
FI - Finlandia 6.374
CN - Cina 4.914
DE - Germania 3.130
BR - Brasile 2.303
UA - Ucraina 2.017
VN - Vietnam 1.926
HK - Hong Kong 1.474
IT - Italia 1.390
TR - Turchia 1.238
GB - Regno Unito 1.027
RU - Federazione Russa 760
FR - Francia 618
SE - Svezia 540
JP - Giappone 423
BD - Bangladesh 420
IN - India 361
CA - Canada 301
MX - Messico 289
PL - Polonia 274
AR - Argentina 213
ZA - Sudafrica 163
ID - Indonesia 120
IQ - Iraq 118
PK - Pakistan 107
ES - Italia 99
EC - Ecuador 96
NL - Olanda 95
BE - Belgio 76
CO - Colombia 75
VE - Venezuela 74
UZ - Uzbekistan 63
MA - Marocco 54
SA - Arabia Saudita 53
PH - Filippine 51
CL - Cile 47
LT - Lituania 45
MY - Malesia 44
AT - Austria 38
TN - Tunisia 37
AE - Emirati Arabi Uniti 34
PY - Paraguay 33
KE - Kenya 31
IR - Iran 27
PE - Perù 26
AU - Australia 25
DZ - Algeria 25
IE - Irlanda 24
JO - Giordania 24
NP - Nepal 24
AL - Albania 22
JM - Giamaica 22
EG - Egitto 21
UY - Uruguay 20
PS - Palestinian Territory 19
AZ - Azerbaigian 18
CH - Svizzera 18
LB - Libano 18
RO - Romania 18
CZ - Repubblica Ceca 17
DO - Repubblica Dominicana 16
KZ - Kazakistan 16
BO - Bolivia 15
DK - Danimarca 15
EU - Europa 14
IL - Israele 14
OM - Oman 14
TH - Thailandia 13
ET - Etiopia 12
GR - Grecia 12
TT - Trinidad e Tobago 12
KR - Corea 11
PT - Portogallo 11
CR - Costa Rica 10
MD - Moldavia 10
BG - Bulgaria 9
GA - Gabon 9
HN - Honduras 9
KG - Kirghizistan 9
LV - Lettonia 9
PA - Panama 9
RS - Serbia 9
CY - Cipro 8
QA - Qatar 8
SV - El Salvador 8
BH - Bahrain 7
GE - Georgia 7
GT - Guatemala 7
HU - Ungheria 7
AM - Armenia 6
BB - Barbados 6
NG - Nigeria 6
SY - Repubblica araba siriana 6
AO - Angola 5
HR - Croazia 5
KW - Kuwait 5
MT - Malta 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 72.109
Salva come PNG Salva come JPEG
Città #
Helsinki 5.836
Singapore 4.519
Ashburn 3.751
Woodbridge 3.027
Fairfield 2.449
San Jose 2.282
Jacksonville 2.168
Chandler 2.078
Houston 1.769
Beijing 1.513
Hong Kong 1.455
Santa Clara 1.452
Ann Arbor 1.271
Seattle 974
Wilmington 951
Cambridge 747
Izmir 680
Ho Chi Minh City 650
Nanjing 620
Los Angeles 550
New York 505
Dallas 453
Hanoi 445
Princeton 440
Tokyo 411
Munich 399
Addison 384
Lauterbourg 358
San Diego 280
Boardman 269
Warsaw 260
Milan 259
São Paulo 255
Shanghai 209
Shenyang 198
Mexico City 193
Nanchang 181
Orem 171
Dearborn 163
Ferrara 138
Turku 137
Hebei 134
Tianjin 133
Hefei 128
Buffalo 125
Washington 118
Changsha 117
London 117
Bremen 110
Montreal 107
Brooklyn 100
Jiaxing 97
Chennai 96
Chicago 95
Denver 94
Johannesburg 93
Jinan 84
Haiphong 83
Da Nang 82
San Francisco 80
Boston 72
Toronto 71
Frankfurt am Main 70
Falls Church 69
Moscow 68
Brussels 67
Mountain View 67
Atlanta 66
Phoenix 66
Stockholm 66
Poplar 64
San Mateo 63
Council Bluffs 62
Manchester 61
Rio de Janeiro 61
Belo Horizonte 60
Rome 59
Baghdad 54
Guangzhou 53
Tashkent 53
The Dalles 53
Hải Dương 51
Norwalk 51
Kunming 49
Zhengzhou 48
Falkenstein 45
Ningbo 45
Redwood City 45
Amsterdam 43
Ankara 40
Biên Hòa 40
Carrara 40
Nuremberg 39
Lahore 38
Quito 38
Brasília 37
Jakarta 37
Auburn Hills 36
Taizhou 36
Tappahannock 36
Totale 48.962
Salva come PNG Salva come JPEG
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.984
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.957
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.957
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 433
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 317
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 286
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 279
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 276
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 274
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 266
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 264
Igf-I influences everolimus activity in medullary thyroid carcinoma 262
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 259
Characterization of a deleted Y chromosome in a male with Turner stigmata 256
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Evaluation of ''ROLL-like'' procedure for minimallyinvasive radioguided parathyroidectomy (MIRP) in hyperparathyroidism (HPT). 254
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 253
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 252
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 249
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 245
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 243
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 242
Circadian profile of plasma calcitonin gene-related peptide in healthy man 241
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 241
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 239
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 239
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 239
A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy 238
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 238
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 237
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 234
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 233
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 233
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 232
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 231
Functional characterization of a new deletion in CDKN1B 5'-UTR region 230
Dermorphin inhibits spinal nociceptive flexion reflex in humans 229
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 229
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 226
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 226
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 225
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 223
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 223
c-myc oncogene alterations in human thyroid carcinomas. 221
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 220
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 218
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 218
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 217
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 217
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 216
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 215
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 214
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Growth hormone induces chemoresistance in breast cancer cells 213
Evidence for androgen receptor gene expression in human thyroid cells and tumours 213
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 213
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 212
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 211
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 211
Growth hormone excess promotes breast cancer chemoresistance 211
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 210
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 210
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 210
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 208
Circadian variations of plasma TSH in patients with severe hypothyroidism 206
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 205
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 203
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 202
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 202
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 202
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 201
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 201
miR-15a and miR-16-1 down-regulation in pituitary adenomas 201
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 201
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 201
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 201
Diurnal rhythm of plasma catecholamines in acromegaly 200
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 200
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 199
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 199
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 197
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 196
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 196
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 194
L’iperplasia surrenale congenita e la pubertà precoce 194
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 193
A new VHL polymorphism in a big family from Ferrara 193
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 192
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 191
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 191
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 190
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 190
Efficacy, safety and adherence to treatment of teriparatide: an observational study 190
Totale 27.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 286.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 18.984
Totale 305.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 0 0 0 0 0 0 210
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20258.348 230 180 625 210 1.067 876 307 351 1.297 985 1.247 973
2025/202629.895 2.330 980 2.087 3.099 3.895 1.660 2.894 1.202 7.887 2.615 998 248
Totale 72.512